|
Status |
Public on Feb 27, 2017 |
Title |
PLX-vehicle_2466_PRE |
Sample type |
RNA |
|
|
Source name |
dorsal skin
|
Organism |
Mus musculus |
Characteristics |
tissue: dorsal skin mouse.no: 2466 Sex: M is.back.anagen: telogen batch: P2 age: 46
|
Treatment protocol |
Mice were aged to 7 weeks, untreated
|
Growth protocol |
Mice were housed in standard conditions with standard chow and water ad libitum
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol followed by Qiagen RNEasy clean-up
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA
|
|
|
Hybridization protocol |
90 microliters of hybridization sample were incubated in the Affymetrix GeneTitan Hybridization Oven instrument for 16 hours at 48C
|
Scan protocol |
Arrays were processed with the Affymetrix GeneTitan Fluidics Station instrument, using the MoGene-1_1-st-v1-96 fluidics script and GeneTitan Hybridization, Wash, and Stain Kit for WT Array Plates. Arrays were scanned in the Affymetrix GeneTitan Multi-Channel (MC) instrument with the AGCC GeneTitan Instrument Control.
|
Description |
Gene expression data from untreated mouse skin
|
Data processing |
CEL files were background corrected and normalized with RMA using oligo in R and a custom probe database which avoids SNPs in FVB and Spretus genomes. Tail and backskin were separately batch-corrected for plate and Log2 transformed
|
|
|
Submission date |
Feb 27, 2017 |
Last update date |
Feb 27, 2017 |
Contact name |
David Quigley |
Organization name |
UCSF
|
Department |
Helen Diller Comprehensive Cancer Center
|
Lab |
Ashworth Lab
|
Street address |
1450 Third St. Room 207
|
City |
San Francisco |
State/province |
CA |
ZIP/Postal code |
94158 |
Country |
USA |
|
|
Platform ID |
GPL11533 |
Series (2) |
GSE52650 |
Gene expression architecture of mouse dorsal and tail skin reveals functional differences in inflammation and cancer |
GSE95421 |
Gene expression architecture of mouse dorsal and tail skin reveals functional differences in inflammation and cancer [telogen/anagen] |
|